While investigations of the latter gene suggest that it plays a role in susceptibility, rather than outcome (9), the HLA–DRB1 gene has been associated with disease severity in IP patients in general and in RA patients in particular (7,10,11). Here, HLA-DRB1 is linked to incontinentia pigmenti.